Fred E Cooperrider

Array ( [id] => 7465659 [patent_doc_number] => 20040101852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of CGG triplet repeat binding protein 1 expression' [patent_app_type] => new [patent_app_number] => 10/303566 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19676 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101852.pdf [firstpage_image] =>[orig_patent_app_number] => 10303566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465639 [patent_doc_number] => 20040101850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of c-src tyrosine kinase expression' [patent_app_type] => new [patent_app_number] => 10/303329 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19657 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101850.pdf [firstpage_image] =>[orig_patent_app_number] => 10303329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635319 [patent_doc_number] => 20030211607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense modulation of survivin expression' [patent_app_type] => new [patent_app_number] => 10/181316 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19328 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211607.pdf [firstpage_image] =>[orig_patent_app_number] => 10181316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469017 [patent_doc_number] => 20040102391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of Gankyrin expression' [patent_app_type] => new [patent_app_number] => 10/302027 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19820 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102391.pdf [firstpage_image] =>[orig_patent_app_number] => 10302027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474157 [patent_doc_number] => 20040097444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of serine/threonine kinase 16 expression' [patent_app_type] => new [patent_app_number] => 10/298953 [patent_app_country] => US [patent_app_date] => 2002-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19466 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097444.pdf [firstpage_image] =>[orig_patent_app_number] => 10298953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474132 [patent_doc_number] => 20040097441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of NIMA-related kinase 6 expression' [patent_app_type] => new [patent_app_number] => 10/295471 [patent_app_country] => US [patent_app_date] => 2002-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21865 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097441.pdf [firstpage_image] =>[orig_patent_app_number] => 10295471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684191 [patent_doc_number] => 20030120055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Novel molecules of the card-related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 10/295981 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 51758 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120055.pdf [firstpage_image] =>[orig_patent_app_number] => 10295981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856721 [patent_doc_number] => 20030130222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Antisense modulation of BH3 interacting domain death agonist expression' [patent_app_type] => new [patent_app_number] => 10/293783 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27537 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130222.pdf [firstpage_image] =>[orig_patent_app_number] => 10293783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367396 [patent_doc_number] => 20040092463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Modulation of PIM-1 expression' [patent_app_type] => new [patent_app_number] => 10/292849 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20290 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092463.pdf [firstpage_image] =>[orig_patent_app_number] => 10292849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367417 [patent_doc_number] => 20040092466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Modulation of ADAM9 expression' [patent_app_type] => new [patent_app_number] => 10/293866 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19547 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092466.pdf [firstpage_image] =>[orig_patent_app_number] => 10293866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367404 [patent_doc_number] => 20040092464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Modulation of mitogen-activated protein kinase kinase kinase 11 expression' [patent_app_type] => new [patent_app_number] => 10/293863 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20293 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092464.pdf [firstpage_image] =>[orig_patent_app_number] => 10293863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367372 [patent_doc_number] => 20040092461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Modulation of phosphodiesterase 1B expression' [patent_app_type] => new [patent_app_number] => 10/292312 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19851 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092461.pdf [firstpage_image] =>[orig_patent_app_number] => 10292312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474122 [patent_doc_number] => 20040097440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of jumonji expression' [patent_app_type] => new [patent_app_number] => 10/293869 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20219 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097440.pdf [firstpage_image] =>[orig_patent_app_number] => 10293869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614411 [patent_doc_number] => 20060116339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Antisense modulation of purinoreceptor p2x3' [patent_app_type] => utility [patent_app_number] => 10/494911 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10359 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116339.pdf [firstpage_image] =>[orig_patent_app_number] => 10494911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821047 [patent_doc_number] => 20060025360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Human cervical cancer protooncogene and protein encoded therein' [patent_app_type] => utility [patent_app_number] => 10/288733 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9245 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025360.pdf [firstpage_image] =>[orig_patent_app_number] => 10288733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683913 [patent_doc_number] => 20030119777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => new [patent_app_number] => 10/281297 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32626 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119777.pdf [firstpage_image] =>[orig_patent_app_number] => 10281297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204743 [patent_doc_number] => 07629321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => utility [patent_app_number] => 10/281349 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 32427 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629321.pdf [firstpage_image] =>[orig_patent_app_number] => 10281349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635343 [patent_doc_number] => 20030211609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense modulation of ara70 expression' [patent_app_type] => new [patent_app_number] => 10/181991 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23219 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211609.pdf [firstpage_image] =>[orig_patent_app_number] => 10181991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801122 [patent_doc_number] => 20030096287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => new [patent_app_number] => 10/281312 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32431 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096287.pdf [firstpage_image] =>[orig_patent_app_number] => 10281312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7187813 [patent_doc_number] => 20050192238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Modulation of the expression of genes dependent on stat-1' [patent_app_type] => utility [patent_app_number] => 10/491644 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11206 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192238.pdf [firstpage_image] =>[orig_patent_app_number] => 10491644 [rel_patent_id] =>[rel_patent_doc_number] =>)